CANAAN X L.P.

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$28.92M
Insider Sells Quantity
13
Insider Sells Sum
$6.84M

Insider Activity of CANAAN X L.P.

The largest purchase of all time was on 2018-05-30 and amounted to 1013312 shares of Iterum Therapeutics plc for $13.17M.

The largest sale of all time was on 2018-03-23 and amounted to 59950 shares of Protagonist Therapeutics, Inc. for $1.24M.

Biography of CANAAN X L.P.

No biography is available at this moment.

2019-05-28PurchaseIDEAYA Biosciences, Inc.
IDYA
10 percent owner
800,000
8.5467%
$10.00$8M-37.23%
2019-05-13PurchaseNextCure, Inc.
NXTC
10 percent owner
50,000
0.2864%
$15.00$750,000+82.16%
2018-05-30PurchaseIterum Therapeutics plc
ITRM
1.01M
15.3014%
$13.00$13.17M-40.58%
2018-05-17SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
77,936
0.3737%
$6.09$474,716+36.06%
2018-05-16SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
58,882
0.2779%
$6.46$380,142+26.05%
2018-05-15SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
115,430
0.547%
$6.48$748,160+25.58%
2018-05-14SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
155,182
0.726%
$6.37$988,447+26.01%
2018-03-23SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
59,950
0.2878%
$20.71$1.24M-60.5%
2018-03-22SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
9,518
0.0471%
$20.62$196,266-59.1%
2018-03-21SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
35,398
0.1693%
$20.61$729,454-60.46%
2018-03-20SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
34,120
0.1619%
$20.61$703,077-60.77%
2018-03-19SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
26,878
0.1271%
$20.57$552,891-60.84%
2018-03-16SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
13,852
0.0663%
$20.51$284,125-60.25%
2018-03-15SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
23,502
0.1116%
$20.64$485,041-60.81%
2018-03-14SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
400
0.0019%
$20.77$8,308-60.46%
2018-03-13SaleProtagonist Therapeutics, Inc.
PTGX
10 percent owner
2,408
0.0115%
$20.84$50,188-60.96%
2016-08-16PurchaseProtagonist Therapeutics, Inc.
PTGX
583,333
7.2004%
$12.00$7M+18.24%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.